RSS

clinical research

The second Life Sciences Sector Deal will include a £46 million investment package as part of a collaboration with healthcare company IQVIA, the government has announced. Read more

News

Health research is thriving in the UK with more people taking part in NHS clinical research than ever before, new figures from the National Institute for Health Research (NIHR) show. Read more

Analysis

In this online exclusive, Mike Novotny of Medrio, looks at the rise of real-world data as a result of patient centric approaches and movement towards precision medicine, and how new tech may help with collection and analysis. Read more

Opinion

Late clinical-stage nanomedicine company, Nanobiotix, has announced its cooperation with the University of Texas MD Anderson Cancer Center to run immunotherapeutic pre-clinical research combining NBTXR3 — the company’s lead product — with Nivolumab. Read more

News

SCORR Marketing, health science marketing and communications firm, has released a new survey report evaluating how satisfied employees of the clinical research industry are and whether salary is an indicator of job satisfaction. Read more

Analysis

Clinical research infrastructure provider, Elligo Health Research, has announced a new partnership with PatientLink Enterprises, to connect physicians and patients to treatment options Read more

News

Global contract research organisation with a focus on medical devices and IVDs, Factory CRO, has acquired MileStone Research Organization — a San Diego based company. Read more

News

The US Food and Drug Administration (FDA) has granted an award to clinical research infrastructure provider, Elligo Health Research to evaluate a harmonised data model that will help in the safety assessment of new oncology therapies. Read more

News

Researchers from London have evaluated a new class of antibiotic, closthioamide (CTA), as a potential treatment for gonorrhoea, finding that it has high anti-gonococcal activity in vitro. Read more

News

Crown Bioscience has announced the publication of two new scientific papers indicating that the FATZO model is a significantly improved rodent model for obesity, dysmetabolism and type 2 diabetes for pre-clinical studies. Read more

News

Researchers from the University of Hertfordshire have developed a new concept that may lead to the discovery of universal anti-influenza drugs, according to findings recently published in the journal Virology. Read more

News

Astellas Pharma and Pfizer have announced an amendment to the clinical research protocol for the Phase III PROSPER trial evaluating XTANDI (enzalutamide) in patients with non-metastatic (M0) castration-resistant prostate cancer (CRPC) Read more

News

According to recently published research in the British Journal of General Practice raised platelet count (thrombocytosis) is a risk marker of cancer in adults and is worthy of further investigation for the prediction of underlying malignancy. Read more

News

Researchers from Yale have found that changes to the surface properties of drug-loaded nanoparticles may improve specificity of drug delivery. The study was recently published in Nature Communications. Read more

News

Scientists from the University of Cambridge are beginning a trial to examine whether Zika virus could be used as a cancer cure for patients with brain tumours. Read more

News

Researchers from the Northwestern University in Illinois, USA, have found that encapsulating ibuprofen in a sugar based metal-organic framework (MOF) makes the drug last twice as long as ibuprofen salts alone. Read more

News

Provider of ethical research review serving 2,300 academic medical centres (AMCs) and hospitals, Western IRB (WIRB), has formed an alliance with Huron. Read more

News

Boyds has joined CTD Holdings’ International Clinical Program team, along with Aptus Clinical and KJC Statistics, to develop orphan drug Trappsol Cyclo with Accenture. Read more

News

Kayentis, a French software provider specialising in solutions for clinical trials, has just finished putting together its strategic committee. Read more

News

Pause for thought: Silvio Severini, managing director, Techorizon, looks at technology in clinical research and asks if it’s time for a new way of thinking Read more

Technology